Royal Sense Ltd
Founded in 2023, Royal Sense Limited deals in Medical Equipment, Surgical Instruments, Surgical Consumables, Laboratory Equipment, Laboratory Reagents, Medical Disposables and Diagnostic Kits.[1]
- Market Cap ₹ 93.1 Cr.
- Current Price ₹ 190
- High / Low ₹ 198 / 104
- Stock P/E 58.6
- Book Value ₹ 37.2
- Dividend Yield 0.00 %
- ROCE %
- ROE %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Stock is trading at 5.11 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | |
|---|---|
| 17.80 | |
| 15.57 | |
| Operating Profit | 2.23 |
| OPM % | 12.53% |
| 0.03 | |
| Interest | 0.06 |
| Depreciation | 0.01 |
| Profit before tax | 2.19 |
| Tax % | 27.85% |
| 1.59 | |
| EPS in Rs | 3.24 |
| Dividend Payout % | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | |
|---|---|
| Equity Capital | |
| Reserves | |
| Total Liabilities | |
| CWIP | |
| Investments | |
| Total Assets |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | |
|---|---|
| -3.87 | |
| -0.52 | |
| 13.13 | |
| Net Cash Flow | 8.74 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2024 | |
|---|---|
| Debtor Days | |
| Inventory Days | |
| Days Payable | |
| Cash Conversion Cycle | |
| Working Capital Days | |
| ROCE % |
Documents
Announcements
-
Closure of Trading Window
18h - Closure of trading window for financial results approval.
-
Board Meeting Outcome for Outcome Of Board Meeting Held On 23Rd September, 2024
23 Sep - Increase in authorized share capital and preferential allotment.
-
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1)(D) SEBI (LODR) Regulations,2015
18 Sep - Board meeting to discuss fund raising and acquisitions.
-
Intimation Pursuant To Regulation 30 Of SEBI(LODR)Regulations, 2015
13 Sep - Royal Sense Limited launches new pharmaceutical products.
- Revised Outcome For The Financial Results For The Quarter And Year Ended 31St March, 2024 12 Sep
Annual reports
No data available.
Business Profile[1] Royal Sense Ltd. (RSL) supplies materials to hospitals, laboratories, institutions and clinics for health services.